Associated Papers
TP53 mutation heterogeneity reveals distinct prognoses in mantle cell lymphoma.
Liu S et al.
Annals of Hematology, 2026
41559357 (PubMed )
Supplement: 277_2026_6771_MOESM2_ESM.xlsx › TableS3
Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations.
Funk JS et al.
Nature Genetics, 2025
39774325 (PubMed )
Supplement: 41588_2024_2039_MOESM5_ESM.xlsx › SuppFig6
Comprehensive Identification of Deleterious TP53 Missense VUS Variants Based on Their Impact on TP53 Structural Stability.
Tam B et al.
International Journal of Molecular Sciences, 2021
34768775 (PubMed )
Supplement: ijms-22-11345-s001.zip › Supplementary_table › Supplementary_table_1.xlsx › Sheet1
Genetic and epigenetic alterations in pancreatic neuroendocrine tumors.
Tirosh A et al.
Journal of Gastrointestinal Oncology, 2020
Spatial distribution of disease-associated variants in three-dimensional structures of protein complexes.
Gress A et al.
Oncogenesis, 2017
Molecular pathology of von HippelLindau disease and the VHL tumour suppressor gene.
Richards FM
Expert Reviews in Molecular Medicine, 2001
Select a paper to view details